Literature DB >> 21294526

Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects.

Yannan Zhao1, Xiaoxing Sun, Guannan Zhang, Brian G Trewyn, Igor I Slowing, Victor S-Y Lin.   

Abstract

The interactions of mesoporous silica nanoparticles (MSNs) of different particle sizes and surface properties with human red blood cell (RBC) membranes were investigated by membrane filtration, flow cytometry, and various microscopic techniques. Small MCM-41-type MSNs (∼100 nm) were found to adsorb to the surface of RBCs without disturbing the membrane or morphology. In contrast, adsorption of large SBA-15-type MSNs (∼600 nm) to RBCs induced a strong local membrane deformation leading to spiculation of RBCs, internalization of the particles, and eventual hemolysis. In addition, the relationship between the degree of MSN surface functionalization and the degree of its interaction with RBC, as well as the effect of RBC-MSN interaction on cellular deformability, were investigated. The results presented here provide a better understanding of the mechanisms of RBC-MSN interaction and the hemolytic activity of MSNs and will assist in the rational design of hemocompatible MSNs for intravenous drug delivery and in vivo imaging.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21294526     DOI: 10.1021/nn103077k

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  85 in total

1.  Blood-nanoparticle interactions and in vivo biodistribution: impact of surface PEG and ligand properties.

Authors:  Neha B Shah; Gregory M Vercellotti; James G White; Adrian Fegan; Carston R Wagner; John C Bischof
Journal:  Mol Pharm       Date:  2012-07-23       Impact factor: 4.939

2.  Impact of silica nanoparticle design on cellular toxicity and hemolytic activity.

Authors:  Tian Yu; Alexander Malugin; Hamidreza Ghandehari
Journal:  ACS Nano       Date:  2011-06-08       Impact factor: 15.881

Review 3.  Intracellular signal modulation by nanomaterials.

Authors:  Salik Hussain; Stavros Garantziotis; Fernando Rodrigues-Lima; Jean-Marie Dupret; Armelle Baeza-Squiban; Sonja Boland
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

4.  Nonporous Silica Nanoparticles for Nanomedicine Application.

Authors:  Li Tang; Jianjun Cheng
Journal:  Nano Today       Date:  2013-06       Impact factor: 20.722

5.  Loss of membrane asymmetry alters the interactions of erythrocytes with engineered silica nanoparticles.

Authors:  Parnian Bigdelou; Amid Vahedi; Evangelia Kiosidou; Amir M Farnoud
Journal:  Biointerphases       Date:  2020-06-29       Impact factor: 2.456

6.  Biomineralization Precursor Carrier System Based on Carboxyl-Functionalized Large Pore Mesoporous Silica Nanoparticles.

Authors:  Sheng Wei; Hua Wu; Xiao-Juan Luo
Journal:  Curr Med Sci       Date:  2020-03-13

Review 7.  Red blood cells as an efficient in vitro model for evaluating the efficacy of metallic nanoparticles.

Authors:  Ridhima Wadhwa; Taru Aggarwal; Noopur Thapliyal; Ashutosh Kumar; Pooja Yadav; Vandana Kumari; Boda Sai Charan Reddy; Pranjal Chandra; Pawan Kumar Maurya
Journal:  3 Biotech       Date:  2019-06-21       Impact factor: 2.406

8.  The membrane axis of Alzheimer's nanomedicine.

Authors:  Yuhuan Li; Huayuan Tang; Nicholas Andrikopoulos; Ibrahim Javed; Luca Cecchetto; Aparna Nandakumar; Aleksandr Kakinen; Thomas P Davis; Feng Ding; Pu Chun Ke
Journal:  Adv Nanobiomed Res       Date:  2020-11-26

9.  OpenRBC: A Fast Simulator of Red Blood Cells at Protein Resolution.

Authors:  Yu-Hang Tang; Lu Lu; He Li; Constantinos Evangelinos; Leopold Grinberg; Vipin Sachdeva; George Em Karniadakis
Journal:  Biophys J       Date:  2017-05-23       Impact factor: 4.033

10.  Influence of geometry, porosity, and surface characteristics of silica nanoparticles on acute toxicity: their vasculature effect and tolerance threshold.

Authors:  Tian Yu; Khaled Greish; Lawrence D McGill; Abhijit Ray; Hamidreza Ghandehari
Journal:  ACS Nano       Date:  2012-03-02       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.